Keyphrases
Persistent Asthma
100%
Tiotropium
100%
Indacaterol
100%
Mannitol
30%
Triple Therapy
30%
Forced Expiratory Volume in 1 Second (FEV1)
20%
Long-acting Antimuscarinic Agents
20%
No Significant Difference
10%
Geometric Mean
10%
Clinical Significance
10%
Clinically Significant
10%
Inhaled Corticosteroids
10%
Provocative Dose
10%
Asthmatic
10%
Cumulative Dose
10%
Airway Hyperresponsiveness
10%
Long-acting beta-agonists
10%
Salbutamol
10%
Signaling Crosstalk
10%
Dose Ratio
10%
B2 Receptor
10%
Receptor Downregulation
10%
Randomized Crossover Design
10%
Non-smoking
10%
Post-challenge
10%
Synergistic Benefits
10%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Indacaterol
100%
Mannitol
30%
Receptor
10%
Beta Adrenergic Receptor Stimulating Agent
10%
Salbutamol
10%
Beta 2 Adrenergic Receptor
10%
Respiratory Tract Allergy
10%